|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 19/00 | |
| C07K 7/06 | |||
| A61K 38/08 | |||
| C07K 1/107 | |||
| A61K 38/00 | |||
| C07K 5/065 | |||
| A61K 38/07 | |||
| A61K 38/26 | |||
| A61K 38/29 | |||
| C09D 101/28 |
| (11) | Number of the document | 2922877 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13857269.8 |
| Date of filing the European patent application | 2013-11-20 | |
| (97) | Date of publication of the European application | 2015-09-30 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/071067 |
| Date | 2013-11-20 |
| (87) | Number | WO 2014/081864 |
| Date | 2014-05-30 |
| (30) | Number | Date | Country code |
| 201261728667 P | 2012-11-20 | US |
| (72) |
NESTOR, John, J., US
|
| (73) |
Eumederis Pharmaceuticals, Inc.,
12707 High Bluff Drive, Suite 200, San Diego, CA 92130,
US
|
| (54) | IMPROVED PEPTIDE PHARMACEUTICALS |
| IMPROVED PEPTIDE PHARMACEUTICALS |